This study identified an oxidase-positive protein in the plasma membrane fraction of the C. elegans N2 strain. The protein with a molecular weight of approximately 85 kDa reacted with antibodies against human and mouse, but not rat, ceruloplasmin and exhibited oxidase activity. Bioinformatic analysis revealed that the F21D5.3 protein possesses four copper-binding sites, similar to those in other multicopper oxidases (MCOs), and plastocyanin-like domains characteristic of MCOs. However, neither an iron-binding domain nor ferroxidase activity, typical features of MCOs, were detected through in silico analysis and or in-gel assays. Despite the absence of ferroxidase activity, these findings suggest that the protein may be the product of the F21D5.3 gene, an ortholog of MCOs in C. elegans. Heat map analysis indicated F21D5.3 expression in the entero-rectal valve cells and both the anterior and posterior intestines. Among the genes associated with copper transport, only cua-1 exhibited a similar expression pattern. In the C. elegans cua-1H828Q strain, which mimics a mutation in human ATP7B linked to Wilson’s disease (WD), oxidase activity was also observed. Notably, both strains showed reduced oxidase activity when cultured with silver nanoparticles (AgNPs). These findings highlight the potential of the cua-1H828Q strain as a model for studying copper and iron metabolism and for developing therapeutic strategies for WD.
1 January 2025 in Reviews on Advanced Materials and Technologies
The increasing use of silver nanoparticles (SNPs) in various fields of human activity concerns about their potential toxicity, particularly for invertebrates that absorb substances through their body surface and for terrestrial mammals. This study focuses on the interference of abiogenic silver with copper metabolism. This is due to the fact that Ag1+ and Cu1+ are isoelectronic, silver ions can be recognized by copper transporters and erroneously incorporated into essential cuproenzymes, thereby impairing their function. We conducted a comparative analysis of the biological effects of ionic silver (from AgNO3) and nanoparticulate silver (30–40 nm spherical SNPs) on both wild-type Caenorhabditis elegans and a mutant strain with impaired copper excretion, as well as on the copper status in the serum of laboratory mice. The results revealed that SNPs exert greater toxicity in nematodes, particularly in those with disrupted copper homeostasis, whereas ionic silver posed a higher potential risk to mice. The findings highlight the need for cautious evaluation of SNPs in biomedical applications.
BACKGROUND: Silver nanoparticles are widely used in various types of industry, but their safety for humans has not been strictly proven. The experimental data currently available on the comparison of the toxic effect of silver nanoparticles and AgNO3 are contradictory and the question of the priority use of silver nanoparticles remains open, especially for organisms with impaired copper metabolism. AIM: The main aim of this study is to compare the effects of silver nanoparticles and AgNO3 on the nematode with normal and impaired copper metabolism and draw conclusions about their toxicity. MATERIALS AND METHODS: In this work, we determined the sublethal concentration (LC50) of AgNPs and AgNO3 for H828Q nematode strain. Using the results obtained, we performed the development assay, thrashing assay and lifespan analysis of the animals. RESULTS: It has been shown that LC50 of silver nanoparticles is lower than the one for AgNO3. Caenorhabditis elegans with impaired copper metabolism treated with silver nanoparticles have a statistically significant reduction in development, level of mobility and lifespan, comparing to animals treated with AgNO3. CONCLUSIONS: The results obtained allow us to conclude that the toxic effect of silver nanoparticles on C. elegans with a genetic defect in copper metabolism is higher comparing to ionic silver.